Bio-Rad Laboratories

$597.30
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$12.80 (+2.19%) Today
$0.00 (0.00%) As of 11:00 PM UTC after-hours

Why Robinhood?

You can buy or sell BIO and other stocks, options, and ETFs commission-free!

About BIO

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Sciences and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA. The listed name for BIO is Bio-Rad Laboratories, Inc.Class A.

CEO
Norman D. Schwartz
Employees
8,000
Headquarters
Hercules, California
Founded
1952
Market Cap
18.17B
Price-Earnings Ratio
4.63
Dividend Yield
Average Volume
302.36K
High Today
$602.28
Low Today
$590.69
Open Price
$593.84
Volume
157.36K
52 Week High
$689.00
52 Week Low
$309.38

BIO Earnings

$0.00
$1.34
$2.67
$4.01
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
per share
Actual
Expected May 6, After Hours

You May Also Like

GAZ
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure